Regulacje i polityka gospodarcza · 20/11/2015
National Institute of Diabetes and Digestive and Kidney Diseases to Grant Exclusive Patent License to Omega Diagnostics Group PLC for In Vitro Diagnostics
The National Institute of Diabetes and Digestive and Kidney Diseases is considering granting an exclusive patent license to Omega Diagnostics Group PLC, a UK-based company, to develop in vitro diagnostics for detecting diseases or pathogenic agents, based on patents filed by the NIDDK.